Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.
Jurisdiction of Incorporation/Organization
CAYMAN ISLANDS
Year of Incorporation/Organization
2019
Item 2 Issuer Principal Place of Business and Contact Information
190 ELGIN AVENUE, GEORGE TOWN
GRAND CAYMAN, E9 KY1-9005
Phone Number:
subscription required
Item 3. Related Persons
Name
-- WELLINGTON ALTERNATIVE INVESTMENTS LLC
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- PROMOTER
Clarification of Response
GENERAL PARTNER
Item 3. Related Persons
Name
-- WELLINGTON MANAGEMENT COMPANY LLP
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- PROMOTER
Clarification of Response
INVESTMENT MANAGER
Item 3. Related Persons
Name
-- WELLINGTON MANAGEMENT INVESTMENT, INC.
Address
subscription required
Relationship(s)
Clarification of Response
MANAGING MEMBER OF THE GENERAL PARTNER
Item 4. Industry Group
POOLED INVESTMENT FUND
- PRIVATE EQUITY FUND
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
First Sale Yet to Occur
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
- Equity
- Pooled Investment Fund Interests
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 12. Sales Compensation
Recipient
CITIGROUP GLOBAL MARKETS INC.
Recipient CRD Number
7059
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
388 GREENWICH STREET
NEW YORK, NY 10013
States of Solicitation
Item 12. Sales Compensation
Recipient
CITI PRIVATE ADVISORY, LLC
Recipient CRD Number
153777
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
388 GREENWICH STREET
NEW YORK, NY 10013
States of Solicitation
Item 13. Offering and Sales Amounts
Total Offering Amount
INDEFINITE
Total Amount Sold
0
Total Remaining to be Sold
INDEFINITE
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
0
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0 Is an estimate
Finders' Fees
0.0 Is an estimate
Clarification of Response
THE RECIPIENTS LISTED IN ITEM 12 ARE PAID AN AMOUNT EQUAL TO A PERCENTAGE OF CERTAIN ASSETS UNDER MANAGEMENT.
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0 Is an estimate
Clarification of Response
Signature and Submission
Issuer Name
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.
Issuer Signature
J. COLIN SULLIVAN
Signer Name
J. COLIN SULLIVAN
Signer Title
VICE PRESIDENT OF THE GENERAL PARTNER
Signature Date
10/03/2019